Clinical significance of NLR, PLR & LMR in COVID-19

The clinical presentation of COVID-19, varies from no symptoms to severe symptoms with complications like acute respiratory failure, acute respiratory distress syndrome, metabolic acidosis, coagulopathy, and septic shock.

A full blood count is a routine, inexpensive and easy test that provides information about formed blood contents. Patients with severe COVID-19 disease present with increased leucocytosis, neutrophilia, lymphopenia, eosinopenia and thrombocytopenia than those with non-severe disease.

Recently, reports on the feasibility of few new haematological parameters like, Neutrophil to Lymphocyte ratio (NLR), Lymphocyte to Monocyte ratio (LMR) and Platelet to Lymphocyte ratio (PLR) in predicting prognosis in patients with SARS-CoV-2 infection have been published. The current study shows that these parameters may be a rapid, cost-effective, widely available, useful prognostic factor in the early screening of critical illness in patients with confirmed COVID-19. These parameters are more sensitive than individual levels of neutrophils, lymphocytes and platelets count. Although further studies with a larger sample size will be needed to properly assess the significance of these parameters in COVID-19.

NLR is an indicator of subclinical systemic inflammation, as neutrophils and lymphocytes play a significant role in inflammation and tumour immunology. NLR may be related to the severity of the infection and also indicates the outcome of the condition. Elevated NLR is found to be an independent prognostic biomarker for COVID-19 patients.

LMR has also been considered as a marker of inflammation including Tuberculosis and various cancers. Low LMR is considered to be a poor prognostic indicator.

PLR is also a novel inflammatory marker. High PLR reflects inflammation, atherosclerosis and platelet activation. Apart from being associated with various diseases, PLR is also an independent prognostic marker to differentiate severe versus non-severe disease in COVID-19 patients.

Early recognition of the severe cases allows for early triaging and timely initiation of management. While many acute phase reactants like C-reactive protein, lactate dehydrogenase, ferritin, and procalcitonin are frequently measured in COVID-19 patients; NLR, LMR and PLR can be easily accessible and are cost-effective especially for developing countries.

Dr Megha Gupta, MD

(Consultant Pathologist, Accuprobe Diagnostics)

Comments

ANA Testing Dilemmas: Unravelling Discordant Results Between ELISA, IFA, and LIA Methods

Antinuclear antibodies (ANAs) are autoantibodies that target components of the cell nucleus. Their presence is associated with various autoimmune diseases, including systemic lupus erythematosus (SLE), Sjögren's syndrome, and rheumatoid arthritis, among others. Detecting ANAs is crucial for diagnosing these diseases, monitoring disease activity, and predicting clinical outcomes. Over the years, several methods have been developed to detect ANAs, each with its significance and limitations. Different methods of ANA detection may yield different results due to variations in antigen specificity, sensitivity, and interpretative criteria. ANA test by ELISA method: The ELISA method offers a semi-quantitative or quantitative determination of IgG antibodies to nuclear and cytoplasmic antigens in the bloodstream and is one of the commonly utilized techniques alongside the indirect immunofluorescence assay (IFA). While ELISA offers specificity and quantification, it is essential to interp

The Thrilling Journey of Working in a Medical Laboratory

Are you curious about what it's like to work in a Medical Laboratory? Well, buckle up, because it's quite the ride! Working in a medical laboratory is like being on a thrilling adventure every day, filled with excitement, challenges, and discoveries. Let's take a closer look at why it's such an exciting journey. The Quest for Answers: In a medical lab, every day is a quest to find answers to important questions. Doctors and technicians work tirelessly to analyze samples and perform tests to uncover the mysteries of diseases and conditions. It's like being a detective, piecing together clues to solve a puzzle and help patients get the treatment they need. The Cutting-Edge Technology: Medical labs are filled with state-of-the-art technology that makes every task fascinating. From high-tech machines that can analyze DNA to automated systems that can process samples with precision and speed, there's always something new to learn and explore. It's like being

Beyond Myeloma: Exploring the Diagnostic Role of Serum Protein Electrophoresis in Diverse Medical Conditions

Serum protein electrophoresis (SPEP) is a valuable diagnostic tool used not only in the detection and monitoring of multiple myeloma but also in various other medical conditions. Here are some examples: Monoclonal Gammopathy of Undetermined Significance (MGUS): SPEP is crucial in diagnosing MGUS, a condition where there is a presence of abnormal proteins (monoclonal proteins or M-proteins) in the blood, which may progress to multiple myeloma or related disorders over time. Amyloidosis: SPEP can help identify abnormal proteins associated with amyloidosis, a condition characterized by the deposition of abnormal proteins in various tissues and organs, leading to organ dysfunction. Waldenström Macroglobulinemia: In this condition, there is an overproduction of a specific type of abnormal protein called IgM. SPEP can help in detecting the presence of IgM in the blood. Chronic Inflammatory Conditions: Chronic inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus

Accuprobe Awareness

Search This Blog

Translate